Skip to main content

Table 2 Acute and late gastrointestinal toxicity

From: Helical intensity-modulated Radiotherapy of the Pelvic Lymph Nodes with Integrated Boost to the Prostate Bed - Initial Results of the PLATIN 3 Trial

Diarrhea

Grade 1

Grade 2

Grade 3

Grade 4

End of RT

28.2%

2.6%

-

-

13 weeks

7.9%

-

-

-

6 months

-

2.7%

-

-

12 months

2.7%

-

-

-

18 months

-

-

-

-

24 months

-

-

-

-

Enteritis

Grade 1

Grade 2

Grade 3

Grade 4

End of RT

15.4%

-

-

-

13 weeks

-

7.9%

-

-

6 months

-

5.4%

-

-

12 months

-

-

-

-

18 months

31.%

-

-

-

24 months

-

4.5%

-

-

Proctitis

Grade 1

Grade 2

Grade 3

Grade 4

End of RT

17.9%

12.8%

-

-

13 weeks

10.5%

-

-

-

6 months

2.7%

2.7%

-

-

12 months

-

-

-

-

18 months

-

-

3.1%

-

24 months

-

-

-

-

  1. Diarrhea: CTC AE grade 1 = increase < 4 stools per day over baseline; grade 2 = increase 4-6 stools per day; grade 3 = increase ≥ 7 stools per day or incontinence or hospitalisation or limiting self care ADL; grade 4 = life-threatening consequences, urgent intervention indicated.
  2. Enteritis: CTC AE grade 1 = asymptomatic; grade 2 = abdominal pain, mucus or blood in stool; grade 3 = severe or persistent abdominal pain, fever, ileus, peritoneal signs; grade 4 = life-threatening consequences, urgent intervention indicated.
  3. Proctitis: CTC AE grade 1 = rectal discomfort, intervention not indicated; grade 2 = symptoms (e.g. rectal discomfort, passing blood or mucus), medical intervention, limiting instrumental ADL; grade 3 = severe symptoms, fecal urgency or stool incontinence, limiting self care ADL; grade 4 = life-threatening consequences, urgent intervention indicated.